ELDN Eledon Pharmaceuticals, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Eledon Pharmaceuticals, Inc. (ELDN) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on March 19, 2026, a 10-Q quarterly report filed on November 14, 2025, an 8-K current report filed on March 19, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Eledon Pharmaceuticals, Inc. (ELDN) (SEC CIK 1404281), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 2.02: Results of Operations and Financial Condition
- • Reporting of financial results for quarter and year ended December 31, 2025
- • Results announced via press release dated March 19, 2026, attached as Exhibit 99.1
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Eledon Pharmaceuticals, Inc. (ELDN) 8-K current reports disclosing material events.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Mar 19, 2026 | — | Analysis | — |
10-K | Mar 19, 2026 | Dec 31, 2025 | — | |
8-K | Jan 2, 2026 | — | — | |
10-Q | Nov 14, 2025 | Sep 30, 2025 | — | |
10-Q | Aug 14, 2025 | Jun 30, 2025 | — | |
10-Q | May 14, 2025 | Mar 31, 2025 | — | |
10-K | Mar 20, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 12, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 19, 2024 | Jun 30, 2024 | — | |
10-Q | May 15, 2024 | Mar 31, 2024 | — | |
10-K | Mar 28, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 9, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 10, 2023 | Jun 30, 2023 | — | |
10-Q | May 11, 2023 | Mar 31, 2023 | — | |
10-K | Mar 30, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 14, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 11, 2022 | Jun 30, 2022 | — | |
10-Q | May 12, 2022 | Mar 31, 2022 | — | |
10-K | Mar 24, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 12, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 12, 2021 | Jun 30, 2021 | — | |
10-Q | May 14, 2021 | Mar 31, 2021 | — | |
10-K | Mar 31, 2021 | Dec 31, 2020 | — | |
10-Q | Nov 16, 2020 | Sep 30, 2020 | — | |
10-Q | Aug 14, 2020 | Jun 30, 2020 | — |
Frequently Asked Questions
What are the latest ELDN SEC filings in 2026?
Eledon Pharmaceuticals, Inc. (ELDN) has filed a 10-K annual report on March 19, 2026, a 10-Q quarterly report on November 14, 2025, an 8-K current report on March 19, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did ELDN file its most recent 10-K annual report?
Eledon Pharmaceuticals, Inc. (ELDN) filed its most recent 10-K annual report on March 19, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view ELDN 10-Q quarterly reports?
Eledon Pharmaceuticals, Inc. (ELDN)'s most recent 10-Q quarterly report was filed on November 14, 2025. SignalX displays every ELDN 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has ELDN filed recently?
Eledon Pharmaceuticals, Inc. (ELDN)'s most recent 8-K was filed on March 19, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find ELDN insider trading activity (Form 4)?
SignalX aggregates every ELDN Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does ELDN file with the SEC?
Eledon Pharmaceuticals, Inc. (ELDN) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new ELDN filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Eledon Pharmaceuticals, Inc. (ELDN).
What is ELDN's SEC CIK number?
Eledon Pharmaceuticals, Inc. (ELDN)'s SEC CIK (Central Index Key) number is 1404281. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1404281 to look up all ELDN filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find ELDN return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Eledon Pharmaceuticals, Inc. (ELDN) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Eledon Pharmaceuticals, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 48+ filings.